GTLS · As filed with the SEC
Chart Industries cash flow statement, by fiscal year
The statement as Chart Industries presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Net income | 37,200,000 | 232,800,000 | 56,900,000 | 25,000,000 | 60,900,000 | 309,500,000 | 46,800,000 | 90,000,000 |
| Loss from discontinued operations, net of tax | (1,600,000) | (3,500,000) | (600,000) | — | — | — | 0 | 34,400,000 |
| Income from continuing operations | 38,800,000 | 236,300,000 | 57,500,000 | — | — | — | 46,800,000 | 55,600,000 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Bridge loan facility fees | 0 | 0 | 26,100,000 | — | — | — | — | — |
| Depreciation and amortization | 281,300,000 | 269,900,000 | 231,100,000 | 81,900,000 | 80,600,000 | 85,200,000 | 78,800,000 | 50,800,000 |
| Employee share-based compensation expense | 17,200,000 | 18,900,000 | 12,600,000 | 10,600,000 | 11,200,000 | 8,900,000 | 9,000,000 | 4,900,000 |
| Financing costs amortization | 19,100,000 | 19,100,000 | 17,200,000 | 2,900,000 | 8,300,000 | 4,300,000 | 3,000,000 | 1,300,000 |
| Interest accretion of convertible notes discount | — | — | — | 0 | 0 | 8,000,000 | 7,600,000 | 9,100,000 |
| Loss on extinguishment of debt | — | — | — | — | — | — | 0 | 0 |
| Realized gain on equity method investment | — | — | 0 | (300,000) | — | — | — | — |
| Unrealized foreign currency transaction loss (gain) | 12,800,000 | — | (3,800,000) | (4,100,000) | (1,100,000) | 2,300,000 | 600,000 | (2,200,000) |
| Unrealized loss (gain) on investments in equity securities | — | — | 14,400,000 | (13,100,000) | (3,200,000) | (13,100,000) | — | — |
| Realized gain on investments in equity securities | — | — | 0 | 0 | (2,600,000) | — | — | — |
| Equity in (earnings) loss of unconsolidated affiliates | — | — | (2,700,000) | 500,000 | (300,000) | — | — | — |
| Deferred income tax benefit | (97,200,000) | (26,100,000) | (79,300,000) | (1,700,000) | (7,900,000) | 1,000,000 | (16,200,000) | 5,000,000 |
| Gain on sale of business | — | — | — | 0 | 0 | (249,400,000) | — | — |
| Asset impairments | — | — | — | 0 | 0 | 16,000,000 | — | 0 |
| Gain on bargain purchase | — | — | — | 0 | 0 | (5,000,000) | — | — |
| Other non-cash operating activities | 13,100,000 | (8,200,000) | (4,100,000) | 11,300,000 | (4,800,000) | 1,500,000 | 900,000 | (2,500,000) |
| Changes in assets and liabilities, net of acquisitions: | ||||||||
| Accounts receivable | — | — | — | — | — | — | — | 25,500,000 |
| Accounts receivable | (2,400,000) | (14,500,000) | (76,500,000) | (45,300,000) | (31,200,000) | (10,100,000) | 23,600,000 | — |
| Inventories | (70,900,000) | 54,900,000 | 20,800,000 | (48,700,000) | (78,100,000) | (34,900,000) | 9,400,000 | (14,100,000) |
| Unbilled contract revenues and other assets | — | — | — | — | — | — | — | (9,100,000) |
| Unbilled contract revenues and other assets | — | — | — | — | — | (5,000,000) | (1,600,000) | — |
| Unbilled contract revenue | (219,200,000) | (267,700,000) | (157,000,000) | (315,400,000) | (71,200,000) | — | — | — |
| Prepaid expenses and other current assets | 8,900,000 | 4,400,000 | — | — | — | — | — | — |
| Accounts payable and other current liabilities | 54,300,000 | 190,100,000 | 236,700,000 | 349,300,000 | (10,400,000) | 62,800,000 | (20,900,000) | (10,200,000) |
| Customer advances and billings in excess of contract revenue | (56,100,000) | (4,000,000) | (58,200,000) | 27,900,000 | 28,500,000 | (9,300,000) | (7,100,000) | 4,900,000 |
| Termination fee paid by Baker Hughes | 258,000,000 | — | — | — | — | — | — | — |
| Long-term assets and liabilities | 37,000,000 | 35,600,000 | — | — | — | — | — | — |
| Net Cash Provided By Continuing Operating Activities | 294,700,000 | 508,700,000 | 234,800,000 | — | — | — | — | — |
| Net Cash Used In Discontinued Operating Activities | (2,000,000) | (5,700,000) | (67,600,000) | — | — | — | 0 | (30,200,000) |
| Net Cash Provided By Operating Activities | 292,700,000 | 503,000,000 | 167,200,000 | 80,800,000 | (21,300,000) | 172,700,000 | 133,900,000 | 119,000,000 |
| INVESTING ACTIVITIES | ||||||||
| Acquisition of business, net of cash acquired | 0 | 0 | (4,322,300,000) | (25,800,000) | (205,100,000) | (51,900,000) | (603,900,000) | (225,800,000) |
| Proceeds from sale of businesses, net of cash divested | — | — | 474,800,000 | 0 | 0 | 317,500,000 | — | — |
| Proceeds from sale of businesses, net of cash divested | 0 | 0 | — | — | — | — | — | — |
| Capital expenditures | (89,900,000) | (120,800,000) | (135,600,000) | (74,200,000) | (52,700,000) | (37,900,000) | (36,200,000) | (35,600,000) |
| Investments | (1,400,000) | (13,100,000) | (11,600,000) | (9,900,000) | (103,900,000) | (50,800,000) | (3,300,000) | — |
| Cash received from settlement of cross-currency swap agreement | — | 0 | 0 | 9,400,000 | — | — | — | — |
| Proceeds from sale of assets | — | — | 8,600,000 | 0 | 0 | 7,900,000 | 0 | 0 |
| Government grants | — | — | — | — | 500,000 | 200,000 | 700,000 | 800,000 |
| Government grants and other | — | — | (1,400,000) | (1,100,000) | — | — | — | — |
| Other investing activities | (2,300,000) | (4,900,000) | — | — | — | — | — | — |
| Net Cash Used In Continuing Investing Activities | (93,600,000) | (138,800,000) | (3,987,500,000) | — | — | — | — | — |
| Net Cash Used In Discontinued Investing Activities | 0 | (2,500,000) | (2,600,000) | — | — | — | 0 | 132,700,000 |
| Cash Provided By Discontinued Operations | — | — | — | — | — | — | 0 | 102,500,000 |
| Net Cash Used In Investing Activities | (93,600,000) | (141,300,000) | (3,990,100,000) | (101,600,000) | (361,200,000) | 185,000,000 | (642,700,000) | (260,600,000) |
| FINANCING ACTIVITIES | ||||||||
| Borrowings on senior secured and senior unsecured notes | — | — | — | 1,940,000,000 | — | — | — | — |
| Borrowings on senior secured and senior unsecured notes | — | 0 | 0 | 635,300,000 | 1,361,100,000 | 215,000,000 | 235,800,000 | 411,700,000 |
| Borrowings on credit facilities | 3,330,400,000 | 3,735,100,000 | 1,895,100,000 | — | — | — | — | — |
| Repayments on credit facilities | (3,267,800,000) | (3,627,200,000) | (1,901,200,000) | (1,128,200,000) | (873,600,000) | (223,100,000) | (451,100,000) | (316,800,000) |
| Repayment of convertible notes | 0 | (258,700,000) | — | — | — | 0 | 0 | (57,100,000) |
| Proceeds from issuance of convertible notes | — | — | — | — | — | — | 0 | 0 |
| Proceeds from issuance of warrants | — | — | — | — | — | — | 0 | 0 |
| Payments for call options related to convertible notes | — | — | — | — | — | — | 0 | 0 |
| Borrowings on term loan | — | — | — | — | — | — | — | 0 |
| Repayments on term loan | — | — | — | — | — | — | — | (5,900,000) |
| Borrowings on term loan | 0 | 0 | 1,747,300,000 | — | 0 | 0 | 450,000,000 | — |
| Repayments on term loan | (175,000,000) | (50,000,000) | (158,300,000) | 0 | (103,100,000) | (344,100,000) | (2,800,000) | — |
| Payments for debt issuance costs | — | — | — | — | — | (1,000,000) | (13,600,000) | (1,400,000) |
| Payments for debt issuance costs | (100,000) | (10,200,000) | (136,200,000) | (4,700,000) | (3,000,000) | — | — | — |
| Payment of contingent consideration | — | — | (4,400,000) | — | — | — | — | — |
| Proceeds from issuance of common stock, net | 0 | 0 | 11,700,000 | 675,500,000 | 0 | 0 | 295,800,000 | — |
| Proceeds from issuance of preferred stock, net | — | 0 | 0 | 388,400,000 | — | — | — | — |
| Payments for equity issuance costs | — | — | 0 | (700,000) | 0 | 0 | (9,500,000) | — |
| Proceeds from exercise of stock options | — | — | 1,000,000 | 2,200,000 | 6,900,000 | 11,000,000 | 9,400,000 | 10,800,000 |
| Common stock repurchases from share-based compensation plans | — | — | (3,000,000) | (3,600,000) | (6,400,000) | (1,900,000) | — | — |
| Common stock repurchases | — | — | — | 0 | 0 | (19,300,000) | (2,000,000) | (2,700,000) |
| Dividend distribution to noncontrolling interests | (6,200,000) | 0 | (12,200,000) | — | 0 | 0 | (400,000) | (400,000) |
| Dividends paid on mandatory convertible preferred stock | (27,200,000) | (27,200,000) | (27,300,000) | — | — | — | — | — |
| Other financing activities | (9,100,000) | (5,500,000) | — | — | — | — | — | — |
| Net Cash (Used in) Provided By Financing Activities | (155,000,000) | (243,700,000) | 1,412,500,000 | 2,504,200,000 | 381,900,000 | (363,400,000) | 511,600,000 | 38,200,000 |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | (500,000) | (3,100,000) | 11,800,000 | (1,900,000) | (11,400,000) |
| Effect of exchange rate changes on cash and cash equivalents | 15,200,000 | (8,600,000) | 6,200,000 | — | — | — | — | — |
| Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents | — | — | (2,404,200,000) | 2,482,900,000 | (3,700,000) | 6,100,000 | 900,000 | (12,300,000) |
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | 59,300,000 | 109,400,000 | — | — | — | — | — | — |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | 310,500,000 | 201,100,000 | 2,605,300,000 | 122,400,000 | 126,100,000 | 120,000,000 | 119,100,000 | 131,400,000 |
| CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD | 369,800,000 | 310,500,000 | 201,100,000 | 2,605,300,000 | 122,400,000 | 126,100,000 | 120,000,000 | 119,100,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.